Otrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml, Nasal Spray
Recommend Otrivine Extra Dual Relief to help relieve nasal congestion symptoms fast
Unique formulation for a blocked and runny nose from colds
- Pharmacy-only medicine*
- Nasal congestion, runny nose, sinus pressure and sneezing are treated simultaneously
- Only product to contain a combination of xylometazoline hydrochloride and ipratropium bromide
Otrivine Extra Dual Relief contains two active ingredients which work to relieve different nasal symptoms
Xylometazoline hydrochloride (0.5 mg/ml)
- Reduces the diameter of blood vessels in the nose to reduce nasal mucosal swelling
- Has a decongestant effect
- Fast effect usually obtained after 5-10 minutes and lasts for 6-8 hours
Ipratropium bromide (0.6 mg/ml)
- Reduces nasal mucus secretion
- Fast effect usually obtained within 15 minutes and lasts for an average of 6 hours
For news, updates and access to more resources please register now to be on our mailing list.
*available without prescription
Download additional resources for your pharmacy
Otrivine Extra Dual Relief ‘How to recommend in Pharmacy’ booklet
This pharmacy guide provides information on differences between topical medication for nasal symptoms of the common cold and for ongoing nasal problems, active ingredients, mode of action, usage and recommendation advice for Otrivine Extra Dual Relief.
Otrivine Extra Dual Relief Patient Leaflet
This customer leaflet provides information on the symptoms of a cold and provides advice including the use of Otrivine sprays with instruction for use.
Otrivine Range Piece
This pharmacy guide provides condensed information on who Otrivine is for, active ingredients, mode of action, usage and recommendation advice for Otrivine Extra Dual Relief.
About Otrivine Extra Dual Relief
Instructions for use
- One puff in each nostril up to 3 times per day
- Leave at least 6 hours between doses
- Not more than 3 applications daily into each nostril
- The product should not be used for more than 7 days
- Always blow your nose before using the nasal spray
Suitable for use from 18 years and older.
Do not use for more than 7 consecutive days.
Pirinase Allergy 0.05% Nasal Spray (fluticasone propionate 50 micrograms per spray). Uses:Prevention and treatment of allergic rhinitis. Dosage and method of use: Adults: Two sprays into each nostril once or twice a day if required. Maintenance: one spray per nostril once a day if possible. Use lowest possible maintenance dose. Max 4 sprays a day in each nostril. Children under 18 years: Not to be used. Contraindications: Hypersensitivity to ingredients. Precautions:Seek medical advice if inadequate relief after 7 days, or require more than 3 months continuous use. Seek medical advice before use with: concomitant corticosteroid use, fever, nasal/sinus infection, recent nasal injury/surgery, nasal ulceration, pregnancy, breast feeding. Caution commencing in those withdrawing from systemic steroids, particularly if impairment of adrenal function suspected. Systemic effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods. Side effects:Dryness and irritation of the nose and throat, unpleasant taste and smell, headache and epistaxis. Hypersensitivity reactions including skin rash and oedema of the face or tongue. Rarely anaphylaxis/anaphylactic reactions and bronchospasm. See SPC for full details.
PL number: PL 44673/0099. Product licence holder:GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. Package quantity and RSP (excl. VAT): 60 sprays £6.58. Date of last revision: August 2016
Active ingredients: Fluticasone propionate.
Other ingredients: Dextrose (anhydrous), Microcrystalline, Cellulose, Carboxymethylcellulose sodium, Polysorbate 80, Purified water, Dilute hydrochloric acid, Preservatives: Benzalkonium chloride, Phenylethylalcohol.
Piriton Syrup and Piriton Allergy Tablets (chlorphenamine maleate) Syrup:4 mg /10 ml. Tablets: 4 mg. Uses: Symptomatic relief of allergic conditions including hayfever. Symptomatic relief of itch associated with chickenpox. Dosage andmethod of use: Adults: 4 mg 4-6 hourly. Max 24 mg/24h. Elderly: Lower dose may be required. Children 6-12 years: 2 mg 4-6 hourly. Max 12 mg/24h. Children 2-6 years: 2.5 ml 4-6 hourly. Max 6 mg/24h. Children 1-2 years: 2.5 ml, twice daily. Max 2 mg/24h.
Contraindications: Hypersensitivity. Treatment with MAOIs within last14 days. Precautions:May seriously affect ability to drive and use machinery. May increase effects of alcohol. Caution in enlarged prostate, severe hypertension, cardiovascular disease or respiratory conditions, hepatic or renal impairment, epilepsy, raised intraocular pressure, intolerance to some sugars. Syrup: Contains sucrose. Contains hydroxybenzoates (E218, E214, E216) which may cause allergic reactions. Contains ethanol. Side effects:Sedation, somnolence, fatigue, disturbance in attention, abnormal coordination, dizziness, headache, blurred vision, nausea, dry mouth, allergic disorders including anaphylaxis. Children and the elderly are more prone to the neurological anticholinergic effects and rarely may become confused or excitable. See SPC for full details. Legal category: P. PL numbers: Syrup:PL 44673/0094. Tablets: PL 44673/0093. Product licence holder:GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. Package quantity and RSP (excl. VAT): Syrup: 150 ml £4.16. Tablets: 30s £3.08, 60s £5.58.
Date of last revision: August 2016.
Active ingredients: Each tablet contains chlorphenamine maleate 4mg.
Also includes: Lactose, maize starch, yellow iron oxide (E 172), magnesium stearate and water.
Active Ingredients: Chlorphenamine Maleate.
Also contains: Sucrose, Glycerol, Ethanol, tingle flavor, peppermint oil, water and a mixture of Methyl, Ethyl and Propyl Hydroxybenzoates (E218, E214 and E216).
Piriteze Allergy Tablets and Piriteze Allergy Syrup(cetirizine hydrochloride). Tablets: 10 mg; Syrup 1 mg/ml.Uses:Symptomatic treatment of perennial rhinitis, seasonal allergic rhinitis and chronic idiopathic urticaria.Dosage and method of use:Adults and adolescents over 12 years: 10 mg daily. Children 6-12 years: 5 mg twice daily. Elderly: As adults if renal function normal. Children under 6 years: Not recommended. Adjust dose in moderate to severe renal impairment. See SPC for details.Contraindications:Hypersensitivity to ingredients, hydroxyzine, piperazine derivatives or severe renal impairment (creatinine clearance <10 ml/min).Precautions:Concomitant alcohol. Predisposition to urinary retention (e.g. spinal cord lesion, prostatic hyperplasia). Epilepsy/risk of convulsions. Caution when driving or operating machinery. Tablets: Not suitable for those with galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Syrup: Not to be taken by those with fructose intolerance. Contains methyl and propyl parahydroxybenzoate which may cause allergic reactions.Side effects:Dizziness, headache, fatigue, somnolence, dry mouth, sore throat, abdominal pain, nausea, diarrhoea, rhinitis, allergic disorders including anaphylaxis and hypersensitivity, suicidal ideation, depression. See SPC for full details. Legal category:GSL (7, 12, 30 tablets & syrup).PL numbers:PL 44673/0097 & 0095.Product licence holder:GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, TW8 9GS, U.K.Package quantity and RSP (excl. VAT):Tablets: 7s £3.73, 12s £5.77, 30s £8.33. Syrup: 70 ml £4.61Date of last revision:August 2016.
Active ingredients: Cetirizine hydrochloride 10mg
Other contains:Microcrystalline cellulose, Lactose, Colloidal anhydrous silica, Magnesium stearate, Hypromellose, Macrogol, Titanium dioxide (E171), Polydextrose.
Active Ingredient:Cetirizine hydrochloride 1mg/1ml
Also contains:Glycerol, Propylene glycol, Sorbitol (E420), Sodium methyl parahydroxybenzoate (E219), Propyl parahydroxybenzoate (E216), Sodium acetate, Acetic acid, Saccharin sodium, Banana flavour, Purified water.
Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution. (0.5 mg/ml xylometazoline hydrochloride and 0.6 mg/ml ipratropium bromide). Indications: Symptomatic treatment of nasal congestion and rhinorrhea in connection with common colds. Dosage: 1 puff in each nostril, up to 3 times daily, with at least 6 hours between doses. Not for use longer than 7 days. Contraindications: Children and adolescents under 18 years. Known hypersensitivity to xylometazoline hydrochloride or ipratropium bromide or any excipients or hypersensitivity to atropine or similar substances. Patients with glaucoma or rhinitis sicca or following trans-sphenoidal hypophysectomy or surgery exposing the dura mater. Warnings and precautions: Use with caution in people with: hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, prostatic hypertrophy, bladder stenosis, pheochromocytoma, angle closure glaucoma, epistaxis, paralytic ileus, cystic fibrosis. Caution in people sensitive to adrenergic substances, which may cause sleep disturbances, dizziness, tremor, cardiac arrythmias or elevated blood pressure. Hypersensitivity reactions may occur. Do not use for more than 7 days. Use during pregnancy or breastfeeding only if clearly necessary. Avoid contact with eyes. Side effects: See SPC for full details. Hypersensitivity reactions (including angioedema, urticaria and bronchospasm). Localised irritation in the nose and throat, nausea, headache and dryness of the nasal mucosa. Systemic cardiovascular effects should be kept in mind in those with cardiovascular disease. In isolated cases, systemic allergic reactions, insomnia, fatigue, urine retention and transient visual disturbances. Price: £6.66 (ex. VAT) Legal Status: P. Licence Number: PL 44673/0153. Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK. Date of revision: April 2019
Recommend Otrivine Extra Dual Relief - Unique formulation for a blocked and runny nose from colds
The Otrivine range
Find out how the Otrivine range can help your customers and patients.